Uploaded June 2023 | Updated September 2026, 2 weeks ago
Dr. Jeremy Shefner is Professor of Neurology and Chief Medical Officer for Clinical Research at the Barrow Neurological Institute. He received his PhD in sensory physiology in 1976, and his MD with Distinction from Northwestern University Medical School in 1983. After completing residency training at the Harvard Longwood Neurology Training Program, he was a fellow in Neuromuscular Disease at the Brigham and Women’s Hospital from 1988-1990. He joined the faculty at BWH in 1990, and moved to Upstate Medical University in Syracuse, NY in 1996, becoming Chair of Neurology in 2004. In October, 2014, Dr. Shefner moved to the Barrow Neurological Institute. Dr. Shefner has been active in designing clinical trials in ALS for many years, and co-founded the Northeast ALS Clinical Trials Consortium (NEALS) in 1996. He was PI for multiple trials in ALS, and has been in leadership positions for many other trials. He has developed numerous outcome measures for clinical trials, including motor unit number estimation, quantitative muscle strength testing using hand held dynamometry, and electrical impedance myography, and has explored their utility in both patients and animal models. In 2014, he was awarded the Sheila Essey Award for ALS Research by the American Academy of Neurology and the ALS Association.
Dr. Jeremy Shefner is Professor of Neurology and Chief Medical Officer for Clinical Research at the Barrow Neurological Institute. He received his PhD in sensory physiology in 1976, and his MD with Distinction from Northwestern University Medical School in 1983. After completing residency training at the Harvard Longwood Neurology Training Program, he was a fellow in Neuromuscular Disease at the Brigham and Women’s Hospital from 1988-1990. He joined the faculty at BWH in 1990, and moved to Upstate Medical University in Syracuse, NY in 1996, becoming Chair of Neurology in 2004. In October, 2014, Dr. Shefner moved to the Barrow Neurological Institute. Dr. Shefner has been active in designing clinical trials in ALS for many years, and co-founded the Northeast ALS Clinical Trials Consortium (NEALS) in 1996. He was PI for multiple trials in ALS, and has been in leadership positions for many other trials. He has developed numerous outcome measures for clinical trials, including motor unit number estimation, quantitative muscle strength testing using hand held dynamometry, and electrical impedance myography, and has explored their utility in both patients and animal models. In 2014, he was awarded the Sheila Essey Award for ALS Research by the American Academy of Neurology and the ALS Association.
